GPCR Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 27

GPCR Therapeutics General Information

Description

Developer of pharmaceuticals designed to treat diseases and symptoms that do not have proper treatment. The company's products include innovative therapeutics targeting cancer-based on novel science of heteromers, enabling patients to address unmet medical needs for the treatment of cancer.

Contact Information

Website
gpcr.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 407, Nakseongdae R&D Center 38
  • Nakseongdae-ro
  • Seoul, Gwanak 08790
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 407, Nakseongdae R&D Center 38
  • Nakseongdae-ro
  • Seoul, Gwanak 08790
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GPCR Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. IPO 01-Jun-2024 Cancelled Clinical Trials - Phase 2
7. Later Stage VC 28-Nov-2023 Completed Clinical Trials - Phase 2
6. Secondary Transaction - Private 28-Oct-2021 Completed Clinical Trials - Phase 2
5. Later Stage VC 30-Jun-2021 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 31-Jul-2019 Completed Startup
3. Early Stage VC (Series A) 30-Sep-2016 Completed Startup
2. Accelerator/Incubator 01-Oct-2015 $2.1M Completed Startup
1. Seed Round 30-Sep-2015 $2.1M $2.1M Completed Startup
To view GPCR Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GPCR Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals designed to treat diseases and symptoms that do not have proper treatment. The company's pr
Drug Discovery
Seoul, South Korea
14 As of 2026

Modiin, Israel
 

Berlin, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GPCR Therapeutics Competitors (4)

One of GPCR Therapeutics’s 4 competitors is BioLineRx, a Formerly VC-backed company based in Modiin, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioLineRx Formerly VC-backed Modiin, Israel
TME Pharma Formerly VC-backed Berlin, Germany
X4 Pharmaceuticals Formerly VC-backed Boston, MA
Sanofi Corporation Gentilly, France
To view GPCR Therapeutics’s complete competitors history, request access »

GPCR Therapeutics Patents

GPCR Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026020039-A1 Cxcr4 inhibitors and/or beta adrenergic receptor inhibitors for mobilization of lymphocytes andimmune cells Pending 18-Jul-2024
AU-2024334309-A1 Gpcr inhibitors and uses thereof Pending 30-Aug-2023
EP-4770661-A2 Gpcr inhibitors and uses thereof Pending 30-Aug-2023
WO-2025050038-A2 Gpcr inhibitors and uses thereof Inactive 30-Aug-2023
WO-2025050038-A3 Gpcr inhibitors and uses thereof Inactive 30-Aug-2023 A61P35/00
To view GPCR Therapeutics’s complete patent history, request access »

GPCR Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GPCR Therapeutics Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Friend Investment Partners (Seoul) Venture Capital Minority
LSK Investment Venture Capital Minority
Medytox Venture Investment Corporate Venture Capital Minority
Midasdong-a Investment Venture Capital Minority
Pharos Asset Management Corporation Minority
You’re viewing 5 of 27 investors. Get the full list »

GPCR Therapeutics Investments (2)

GPCR Therapeutics’s most recent deal was a PIPE with Parataxis Korea for . The deal was made on 22-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Parataxis Korea 22-Jan-2024 PIPE Other Financial Services
GPCR Therapeutics (GPC-100 (Rights) in Taiwan) 01-Nov-2020 Corporate Asset Purchase Buildings and Property
To view GPCR Therapeutics’s complete investments history, request access »

GPCR Therapeutics FAQs

  • When was GPCR Therapeutics founded?

    GPCR Therapeutics was founded in 2013.

  • Where is GPCR Therapeutics headquartered?

    GPCR Therapeutics is headquartered in Seoul, South Korea.

  • What is the size of GPCR Therapeutics?

    GPCR Therapeutics has 14 total employees.

  • What industry is GPCR Therapeutics in?

    GPCR Therapeutics’s primary industry is Drug Discovery.

  • Is GPCR Therapeutics a private or public company?

    GPCR Therapeutics is a Private company.

  • What is GPCR Therapeutics’s current revenue?

    The current revenue for GPCR Therapeutics is .

  • How much funding has GPCR Therapeutics raised over time?

    GPCR Therapeutics has raised $56.1M.

  • Who are GPCR Therapeutics’s investors?

    Friend Investment Partners (Seoul), LSK Investment, Medytox Venture Investment, Midasdong-a Investment, and Pharos Asset Management are 5 of 27 investors who have invested in GPCR Therapeutics.

  • Who are GPCR Therapeutics’s competitors?

    BioLineRx, TME Pharma, X4 Pharmaceuticals, and Sanofi are competitors of GPCR Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process